Investigation of differential impact of mutations associated with complex HIV-1 protease multi-drug resistance patterns using bio-informaticsresistance determination (BIRD)

被引：0
|
作者：
Van Marck, H.
Dierynck, I.
Muyldermans, G.
Borozdina, L.
Keen, R.
Kraus, G.
de Béthune, M-P
Hallenberger, S.
Hertogs, K.
机构：
[1] Tibotec BVBA, Mechelen, Belgium
[2] Virco BVBA, Mechelen, Belgium
[3] Centocor EGEA, San Diego, CA USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 28 条
  • [1] Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: Mechanism of drug recognition and resistance
    Liu, Zhigang
    Yedidi, Ravikiran S.
    Wang, Yong
    Dewdney, Tamaria G.
    Reiter, Samuel J.
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Kovari, Ladislau C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 437 (02) : 199 - 204
  • [2] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92
  • [3] Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease
    Dewdney, Tamaria G.
    Wang, Yong
    Liu, Zhigang
    Sharma, Shiv K.
    Reiter, Samuel J.
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Woster, Patrick M.
    Kovari, Ladislau C.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (23) : 7430 - 7434
  • [4] Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex
    Liu, Zhigang
    Yedidi, Ravikiran S.
    Wang, Yong
    Dewdney, Tamaria G.
    Reiter, Samuel J.
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Kovari, Ladislau C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (02) : 232 - 238
  • [5] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [6] Differential Impact of Resistance-Associated Mutations to Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on HIV-1 Replication Capacity
    Hsieh, Szu-Min
    Pan, Sung-Ching
    Chang, Sui-Yuan
    Hung, Chien-Ching
    Sheng, Wang-Huei
    Chen, Mao-Yuan
    Chang, Shan-Chwen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (08) : 1117 - 1122
  • [7] Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase
    Ceccherini-Silberstein, F
    Santoro, M
    Svicher, V
    Gori, C
    Zaccarelli, M
    Forbici, F
    d'Arrigo, R
    Trotta, MP
    Bellocchi, MC
    Visco-Comandini, U
    Giannella, S
    Bertoli, A
    Antinori, A
    Perno, CF
    ANTIVIRAL THERAPY, 2004, 9 (04) : U84 - U84
  • [8] Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India
    Azam, Mohd
    Malik, Abida
    Rizvi, Meher
    Singh, Supriya
    Gupta, Poonam
    Rai, Arvind
    VIRUS GENES, 2013, 47 (03) : 422 - 428
  • [9] Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India
    Mohd Azam
    Abida Malik
    Meher Rizvi
    Supriya Singh
    Poonam Gupta
    Arvind Rai
    Virus Genes, 2013, 47 : 422 - 428
  • [10] The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
    Mbisa, Jean L.
    Gupta, Ravi K.
    Kabamba, Desire
    Mulenga, Veronica
    Kalumbi, Moxmalama
    Chintu, Chifumbe
    Parry, Chris M.
    Gibb, Diana M.
    Walker, Sarah A.
    Cane, Patricia A.
    Pillay, Deenan
    RETROVIROLOGY, 2011, 8
123